SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases

• Published in: Molecular biology of the cell Vol. 27; no. 9; pp. 1409 - 1419
• Main Authors: Bendris, Nawal, Williams, Karla C, Reis, Carlos R, Welf, Erik S, Chen, Ping-Hung, Lemmers, Bénédicte, Hahne, Michael, Leong, H S, Schmid, Sandra L
• Format: Journal Article
• Language: English
• Published: United States American Society for Cell Biology 01.05.2016; The American Society for Cell Biology
• Subjects: Animal biology; Biochemistry, Molecular Biology; Cancer; Cellular Biology; Immunology; Life Sciences
• ISSN: 1059-1524; 1939-4586
• DOI: 10.1091/mbc.e16-02-0101

Despite current advances in cancer research, metastasis remains the leading factor in cancer-related deaths. Here, we identify sorting nexin 9 (SNX9) as a new regulator of breast cancer metastasis. We detected an increase in SNX9 expression in human breast cancer metastases compared with primary tumors and demonstrated that SNX9 expression in MDA-MB-231 breast cancer cells is necessary to maintain their ability to metastasize in a chick embryo model. Reciprocally, SNX9 knockdown impairs the process. In vitro studies using several cancer cell lines derived from a variety of human tumors revealed a role for SNX9 in cell invasion and identified mechanisms responsible for this novel function. We showed that SNX9 controls the activation of RhoA and Cdc42 GTPases and also regulates cell motility via the modulation of well-known molecules involved in metastasis, namely RhoA-ROCK and N-WASP. In addition, we have discovered that SNX9 is required for RhoGTPase-dependent, clathrin-independent endocytosis, and in this capacity, can functionally substitute to the bona fide Rho GAP, GRAF1 (GTPase Regulator Associated with Focal Adhesion Kinase). Together, our data establish novel roles for SNX9 as a multifunctional protein scaffold that regulates, and potentially coordinates, several cellular processes that together can enhance cancer cell metastasis.